Article
Spontaneous mutations to delamanid and pretomanid resistance in Mycobacterium tuberculosis: SNPs confer high-level resistance.
International journal of antimicrobial agents - 1 Jun 2026
Zhang Qian, Xu Peng, Zhang Xuecong, Pi Rui, Chen Yiwang, Takiff Howard, Gao Qian
Abstract excerpt
OBJECTIVES: Multidrug-resistant tuberculosis (MDR-TB) remains a major global health threat. Delamanid (DLM) and pretomanid (PMD) are core drugs in new multidrug-resistant tuberculosis regimens, but the spectrum of their resistance mutations is poorly defined. METHODS: To investigate these mutations, five parallel in vitro experiments selected for resistance to DLM or PMD. Mycobacterium tuberculosis H37Rv cultures...
Topics
- Mycobacterium tuberculosis
- Microbial Sensitivity Tests
- Polymorphism, Single Nucleotide
- Antitubercular Agents
- Nitroimidazoles
- Whole Genome Sequencing
- Mutation
- Humans
- Oxazoles
- Drug Resistance, Multiple, Bacterial
